Rejected Bachelor contestant Georgia Tripos has avoided a prison sentence despite being caught red-handed dealing cocaine. Tripos had been addicted to drugs at the time and 'submerged' in Melbourne's ...
SAN FRANCISCO, March 31, 2015 - Element Payment Services, a Vantiv company (VNTV) and a provider of payments technology and services for small and medium-sized businesses (SMBs), today announced that ...
ST. LOUIS--(BUSINESS WIRE)--Oct. 5, 2004--Tripos, Inc. (Nasdaq:TRPS), a leading provider of drug discovery informatics products and chemistry research, today announced the release of SYBYL(R) 7.0, the ...
Tripos Releases Newest SYBYL-X Discovery Software for Computational Chemistry and Molecular Modeling
ST. LOUIS--(BUSINESS WIRE)--Tripos™, a leading provider of drug discovery informatics products and services, today announced the release and general availability of the latest version of its flagship ...
Tripos International, the leading provider of drug discovery informatics products and services, today announced that it has completed the acquisition of Pharsight Corporation, a leader in software, ...
"It turns out that chemistry is a cottage industry in Cornwall," says John P. McAlister III, chief executive officer of Tripos. Gazing from the atrium window at the firm's drug discovery research ...
Melbourne woman Georgia Tripos pleaded guilty to trafficking cocaine and ethylpentylone and knowingly deal with proceeds of crime in the County Court of Victoria on Thursday. The 29-year-old former ...
Tripos International is the newly formed private company that resulted from the break up of the former Tripos, which was spun out of Washington University in 1979. When Vector Capital acquired Tripos ...
Tripos, Inc. has announced collaborations with several prominent pharmaceutical and life science organizations across Europe and North America to provide knowledge-driven customized chemistry services ...
Tripos, Inc. has announced that Tripos Discovery Research Ltd. has formed research collaboration with Cara Therapeutics. Cara is focused on developing therapeutics to treat medical conditions ...
Tripos has already gained the approval of shareholders representing 33% of common stock. Tripos plans on purchasing Pharsight for approximately $57 million in cash. The combined companies will provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results